Delivery Order SPE2DB22D2103-SPE2DB24FR9CC
Award Date 3/22/24
Potential Completion Date 3/25/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The contract, valued at $11,335.99, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 25, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,279.49 firm-fixed-price delivery order is for the supply of NASCOBAL 500 MCG NASAL SPRAYS, with a completion date of April 3, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a ceiling value of $2,259.56 and runs through January 30, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,225.05, is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a completion date of December 22, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS57W, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,719.53 firm fixed-price delivery order is for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has an ultimate completion date of March 13, 2023 and was awarded on March 10, 2023. It is not designated as a set-aside. Amerisourcebergen Drug Corp, a subsidiary of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Qnasl 80 mcg nasal spray (10.6 grams) with a ceiling value of $4,980.26. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,720.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4564042929 ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product, with a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $25,129.86. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,434.44 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dristan 0.05% nasal spray. The contract has a period of performance through September 6, 2024. AmerisourceBergen, as the prime contractor, will provide these pharmaceuticals to support military treatment facilities and other federal healthcare programs. This delivery order is part of a larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $46,253.35 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a variety of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen delivers specialty, brand name,...